Výsledky vyhledávání

Akademický článek

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain

Autor: Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 11, Pp 395-403 (2019)

Max Schlueter,1 Elaine Finn,1 Silvia Díaz,2 Tatiana Dilla,2 José Inciarte-Mundo,3 Walid Fakhouri41IQVIA, Real World Evidence, London N1 9JY, UK; 2Lilly Spain, Health Outcomes & RWE, Alcobendas 28108, Spain; 3Lilly Spain, Medical, Alcobendas 28108,

Externí odkaz: https://doaj.org/article/a988bdbb23874157ab44df5cfc1dfca5

Zobrazit plný text záznamu

Akademický článek

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain

Autor: Johansson E, Nuñez M, Svedbom A, Dilla T, Hartz S

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 747-759 (2018)

Erin Johansson,1 Mercedes Nuñez,2 Axel Svedbom,1 Tatiana Dilla,2 Susanne Hartz3 1Access, Commercialisation & Communications, ICON plc, Stockholm, Sweden; 2Health Outcomes and Real World Evidence, Eli Lilly, Madrid, Spain; 3Global Patient Outcomes an

Externí odkaz: https://doaj.org/article/1eb8ec15b7204dfc937b9c9f0b6f3c52

Zobrazit plný text záznamu

Akademický článek

Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population

Autor: Dilla T, Lizan L, Paz S, Garrido P, Avendaño C, Cruz-Hernández JJ, Espinosa J, Sacristán JA

Publikováno v: Patient Preference and Adherence, Vol 2016, Iss Issue 1, Pp 1-7 (2015)

Tatiana Dilla,1 Luís Lizan,2 Silvia Paz,2 Pilar Garrido,3 Cristina Avendaño,4 Juan J Cruz-Hernández,5 Javier Espinosa,6 José A Sacristán1 1Medical Department, Lilly, Madrid, 2Outcomes’10, Jaime I University, Castellón, 3Medical Oncology Depar

Externí odkaz: https://doaj.org/article/aa2dae8df5a047f8920d7a5126e5c9e7

Zobrazit plný text záznamu

Akademický článek

Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia

Autor: Dilla T, Ciudad A, Álvarez M

Publikováno v: Patient Preference and Adherence, Vol 2013, Iss default, Pp 275-284 (2013)

Tatiana Dilla, Antonio Ciudad, María ÁlvarezDepartment of Clinical Research and Development, Lilly, S.A. Alcobendas, SpainPurpose: There is strong evidence supporting the link between nonadherence to antipsychotic medication and relapse of schizoph

Externí odkaz: https://doaj.org/article/27805033cc604125b7b578a28d320aa5

Zobrazit plný text záznamu

Akademický článek

Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics

Autor: Bernardo M, San L, Olivares JM, Dilla T, Polavieja P, Gilaberte I, Álvarez M, Ciudad A

Publikováno v: Patient Preference and Adherence, Vol 2011, Iss default, Pp 601-610 (2011)

Miguel Bernardo1, Luis San2, José M Olivares3, Tatiana Dilla4, Pepa Polavieja4, Inmaculada Gilaberte4, María Álvarez4, Antonio Ciudad41Department of Psychiatry, Hospital Clinic, University of Barcelona/IDIBAPS/CIBERSAM, Barcelona, 2Department of C

Externí odkaz: https://doaj.org/article/fb44f2042b3f4bf6b24d52ae31408779

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání